Ophthalmology

GRaSS Study

Mass General Brigham Mass Eye and Ear (MEEI)

An older patient getting an eye exam with special equipment
Mass General Brigham, Mass Eye and Ear
Harvard Medical School, Department of Ophthalmology

Glaucoma and Retinopathy Screening Study (GRaSS)

Glaucoma is the second leading cause of blindness in the United States, with over half of those with glaucoma unaware that they have this potentially blinding disease, especially underserved minority populations.  We will use innovative AI-assisted screening for glaucoma using retinal photographs already being obtained to identify diabetic eye disease in community clinics serving at-risk populations.  The project will also track the outcomes of these individuals and compare these to others undergoing diabetic eye disease screening who are not being screened for glaucoma to determine the costs and benefits of the program.

Leadership

Our Team

  • Grayson W. Armstrong, MD, MPH

    • Director, Ophthalmology Emergency Service, Massachusetts Eye and Ear
    • Instructor in Ophthalmology, Harvard Medical School
    Grayson W. Armstrong, MD, MPH

  • Adrienne Allen, MD, MPH

    • Medical Director of Value Based Care Transformation, Massachusetts Eye and Ear
    Adrienne Allen, MD, MPH

  • Kanza Aziz, MD

    • Research Fellow in Ophthalmology, Harvard Medical School

  • Asahi Fujita, MD

    • Research Fellow in Ophthalmology, Harvard Medical School

Enrolling Details and Eligibility

Enrollment will occur at Mass General Brigham primary care locations. Eligibility includes:

  • Individuals with diabetes undergoing artificial intelligence-based screening for diabetic eye disease for clinical care

Contact Us

For questions or more information about the Glaucoma and Retinopathy Screening Study (GRaSS) at Mass General Brigham Mass Eye and Ear (MEEI), please contact us.

Learn More About the GRaSS Study